You are here

  • Home
  • Archive
  • Volume 86, Issue 9
  • Dantrolene for cerebral vasospasm after subarachnoid haemorrhage: a randomised double blind placebo-controlled safety trial

Article info

Article menu
Download PDFPDF
Cerebrovascular disease
Research paper
Dantrolene for cerebral vasospasm after subarachnoid haemorrhage: a randomised double blind placebo-controlled safety trial

Authors

  • Susanne Muehlschlegel Departments of Neurology (Neurocritical Care), University of Massachusetts Medical School, Worcester, Massachusetts, USA Department of Anesthesia/Critical Care, University of Massachusetts Medical School, Worcester, Massachusetts, USA Department of Surgery, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Raphael Carandang Departments of Neurology (Neurocritical Care), University of Massachusetts Medical School, Worcester, Massachusetts, USA Department of Surgery, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Wiley Hall Departments of Neurology (Neurocritical Care), University of Massachusetts Medical School, Worcester, Massachusetts, USA Department of Surgery, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Nisha Kini Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Saef Izzy Departments of Neurology (Neurocritical Care), University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Bridget Garland Departments of Neurology (Neurocritical Care), University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Cynthia Ouillette Departments of Neurology (Neurocritical Care), University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Imramsjah M J van der Bom Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Thomas F Flood Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Matthew J Gounis Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • John P Weaver Department of Neurosurgery, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Bruce Barton Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Ajay K Wakhloo Departments of Neurology (Neurocritical Care), University of Massachusetts Medical School, Worcester, Massachusetts, USA Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA Department of Neurosurgery, University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Susanne Muehlschlegel, Departments of Neurology (Neurocritical Care), Anesthesia/Critical Care and Surgery, University of Massachusetts Medical School, 55 Lake Ave. North, S5, Worcester, MA 01655, USA; susanne.muehlschlegel{at}umassmemorial.org
View Full Text

Citation

Muehlschlegel S, Carandang R, Hall W, et al
Dantrolene for cerebral vasospasm after subarachnoid haemorrhage: a randomised double blind placebo-controlled safety trial
Journal of Neurology, Neurosurgery & Psychiatry 2015;86:1029-1035.

Publication history

  • Received June 12, 2014
  • Revised September 29, 2014
  • Accepted September 30, 2014
  • First published October 24, 2014.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions